Long Run Wealth Advisors’s CVS Health CVS Stock Holding History

Long Run Wealth Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-49,921	Closed	-$2.95M	–	105
2024 Q2	$2.95M	Buy	49,921 +6,485	+15%	+$406K	0.75%	40
2024 Q1	$3.46M	Buy	43,436 +2,104	+5%	+$161K	0.91%	34
2023 Q4	$3.26M	Buy	41,332 +3,488	+9%	+$248K	0.94%	31
2023 Q3	$2.64M	Buy	37,844 +1,828	+5%	+$130K	0.86%	30
2023 Q2	$2.49M	Buy	36,016 +4,930	+16%	+$351K	0.79%	32
2023 Q1	$2.31M	Buy	31,086 +8,037	+35%	+$674K	0.79%	36
2022 Q4	$2.15M	Buy	23,049 +692	+3%	+$66.8K	0.77%	34
2022 Q3	$2.13M	Sell	22,357 -8,488	-28%	-$840K	0.84%	32
2022 Q2	$2.86M	Buy	30,845 +63	+0.2%	+$6.15K	1.11%	25
2022 Q1	$3.11M	Sell	30,782 -6,802	-18%	-$715K	1.09%	26
2021 Q4	$3.88M	Buy	+37,584	New	+$3.47M	1.35%	22

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Long Run Wealth Advisors's CVS Position: Q3 2024 in Review

Long Run Wealth Advisors sold out of CVS Health (CVS) in Q3 2024, closing a stake of 49,921 shares — an estimated $2.95M sold.

Long Run Wealth Advisors first reported a position in CVS in Q4 2021 and held it in 11 quarters. The position peaked at $3.88M in Q4 2021. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Long Run Wealth Advisors reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Long Run Wealth Advisors sold 49,921 CVS Health shares in Q3 2024, an estimated $2.95M.
Long Run Wealth Advisors first reported a position in CVS Health in Q4 2021 and held it in 11 quarters.
Long Run Wealth Advisors's CVS Health position peaked at $3.88M in Q4 2021.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Long Run Wealth Advisors's 13F filing for Q3 2024, filed 30 Oct 2024.